Edwards Lifesciences Corp (EW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2000 | 09-2000 | 06-2000 | 03-2000 | 12-1999 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -272,000 | -287,600 | -292,000 | 17,300 | 82,000 |
| Depreciation Amortization | 74,000 | 59,400 | 43,900 | 21,400 | 84,000 |
| Income taxes - deferred | -1,000 | 2,600 | N/A | N/A | 2,000 |
| Accounts receivable | -8,100 | -1,200 | -11,800 | 5,500 | 14,000 |
| Other Working Capital | -12,000 | -20,200 | -34,100 | -16,000 | -2,000 |
| Other Operating Activity | 356,100 | 334,500 | 338,600 | -9,700 | -4,000 |
| Operating Cash Flow | $137,000 | $87,500 | $44,600 | $18,500 | $176,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -46,000 | -34,900 | -21,200 | -10,000 | -42,000 |
| Net Acquisitions | 0 | 10,000 | N/A | N/A | 0 |
| Purchase Of Investment | -41,000 | -39,500 | -39,500 | -17,000 | N/A |
| Purchase Sale Intangibles | -1,000 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 12,000 | 0 | 0 | 0 | -7,000 |
| Investing Cash Flow | $-75,000 | $-64,400 | $-60,700 | $-27,000 | $-49,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 251,900 | 219,000 | 210,000 | 210,000 | N/A |
| Debt Issued | 448,600 | -74,000 | -158,500 | -192,000 | N/A |
| Debt Repayment | -669,600 | -87,000 | -32,000 | N/A | -127,000 |
| Common Stock Issued | 4,100 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -72,000 | -71,400 | -3,000 | -3,000 | 0 |
| Financing Cash Flow | $-37,000 | $-13,400 | $16,500 | $15,000 | $-127,000 |
| Exchange Rate Effect | 3,000 | 3,500 | 1,600 | N/A | 0 |
| End Cash Position | 28,000 | 13,200 | 2,000 | 6,500 | 0 |
| Net Cash Flow | $28,000 | $13,200 | $2,000 | $6,500 | $0 |
| Free Cash Flow | |||||
| Operating Cash Flow | 137,000 | 87,500 | 44,600 | 18,500 | 176,000 |
| Capital Expenditure | -46,000 | -34,900 | -21,200 | -10,000 | -42,000 |
| Free Cash Flow | 91,000 | 52,600 | 23,400 | 8,500 | 134,000 |